about
Andrographolide attenuates LPS-stimulated up-regulation of C-C and C-X-C motif chemokines in rodent cortex and primary astrocytesF-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagyAndrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERKRelaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia.Brain lipidomes of subcortical ischemic vascular dementia and mixed dementiaCystathionine β-synthase inhibition is a potential therapeutic approach to treatment of ischemic injury.Genome-wide profiling of alternative splicing in Alzheimer's diseaseExtracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).Markers of cardiac dysfunction in cognitive impairment and dementia.Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease.Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's diseaseCharacterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM miceIncreased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementiasCdk5-mediated phosphorylation of delta-catenin regulates its localization and GluR2-mediated synaptic activity.Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes.Neurochemical basis for symptomatic treatment of Alzheimer's disease.Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia.Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease.An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementiasAgeing and the telomere connection: An intimate relationship with inflammation.Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.NeuroAiD® (MLC601) and amyloid precursor protein processing.Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease.Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex.Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.iTRAQ quantitative clinical proteomics revealed role of Na(+)K(+)-ATPase and its correlation with deamidation in vascular dementia.Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease.Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients.Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease.Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease.Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis.Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias.Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease.
P50
Q27303312-028C1281-9CBC-422F-B9D2-06B350B1028BQ28118029-AE13D016-11B4-46A4-8F06-1B5018280DADQ28389948-8DD2C791-90C1-4652-A52E-301E4D6A3C20Q33606810-9B22D700-3977-4F3A-AA15-C87E828E53D7Q33624463-BBB4BDEF-8E61-4665-80ED-8D61C46855A1Q33906496-C030ACAB-45FA-4A68-944F-D5DE3801938DQ35418764-992A6B99-EA5E-4C9C-B7F5-DA5949D478AFQ35951836-5CCCFE45-CDD4-47B5-8642-7D7C97DD848EQ36106782-061E9566-56A5-4D01-AA22-EA18B72543C8Q36152775-85248441-3ECA-499F-818A-4396FF0DE62BQ36694586-DDB23DCE-5B47-495B-A49D-D9349561EFC8Q37155987-B0000377-25EA-426C-A433-4705A4235ADBQ37230895-78264292-D286-424E-A16F-BDDAAEA7C31FQ37243713-52855EB7-1F35-4A00-A987-0EADF0F2FA72Q37616216-8B6EE107-32F5-473E-8A9C-1CB31B21C94AQ37654102-4A0EFAE5-5974-4963-BE40-5554055B72AAQ37684036-C340F76F-FD85-49CB-8339-5F431F65BB85Q37692586-1A66AB0A-869E-4085-ABC3-C01881423E95Q37726734-DB5DDB9D-74CF-442C-8B21-B8EDE86378DBQ38209851-982A612A-AE98-47C5-A957-D778F00B0BE3Q38455016-A97AF136-54D7-45A6-B9DD-A056B26A033BQ38628562-2B5DAF8C-50AE-416E-9EB7-04F621B3148BQ38652495-295E8BF9-DADC-416A-8106-A3BD6FF93B5EQ38890587-620EED9A-A565-4104-9179-D980416ACB3AQ39168630-C28FE8C5-4909-4C48-8B72-ADB469870647Q43158595-A1376818-0B9D-44EB-A5BB-D479B3990E5DQ43264302-3C1E492B-1612-4B88-B2DB-6E7C6CE5BFBDQ43575314-2A3552A1-DAE9-4928-8A8C-0915DF321657Q44085385-EF8686DE-A8DE-4A30-88E0-BDC2602A7D2CQ44362099-C53F3EFD-FF29-472E-987F-9C69BAC16DE4Q44438171-1EDFD9BA-624E-4DB1-953D-D0D3B0404C98Q44522663-F451CE3B-4F69-4121-AE9B-DF57A73486CEQ44774292-699B9B6F-349F-4EB5-914B-930EB5B74EB1Q45155062-EFD9EA92-59E9-45A5-B59D-39EE21B1CD0FQ46582617-595CFED5-BCE3-45EB-A66E-C1B99113341AQ46675666-1E7224BF-0552-4F94-B05D-BEFEC849A8E4Q46676906-1FE5A9C2-85D5-4496-A457-A02999FE9798Q46731830-8CFD792E-5FA8-42FE-93F2-CD5CA95D5159Q46940489-0ED1DB68-ADD2-48F4-8DB5-87D68DA4FB1AQ47280377-98DBA0C1-11EB-43EB-8039-2F8D88564098
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mitchell K.p. Lai
@ast
Mitchell K.p. Lai
@en
Mitchell K.p. Lai
@es
Mitchell K.p. Lai
@nl
Mitchell K.p. Lai
@sl
type
label
Mitchell K.p. Lai
@ast
Mitchell K.p. Lai
@en
Mitchell K.p. Lai
@es
Mitchell K.p. Lai
@nl
Mitchell K.p. Lai
@sl
prefLabel
Mitchell K.p. Lai
@ast
Mitchell K.p. Lai
@en
Mitchell K.p. Lai
@es
Mitchell K.p. Lai
@nl
Mitchell K.p. Lai
@sl
P1053
E-6641-2011
P106
P21
P31
P3829
P496
0000-0001-7685-1424
P569
2000-01-01T00:00:00Z